Pharmaceutical Technology, September 2015 APIs, Excipients, and Manufacturing Supplement (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-01-2015
Volume 2015 Supplement
Issue 3

Click the title above to open the Pharmaceutical Technology September 2015 APIs, Excipients, and Manufacturing Supplement in an interactive PDF format.

External Link - PharmTech_NA_Septsupp2015.pdf

Articles in this issue
Lessons Learned from FDA Inspections of Foreign API Facilities
Lessons Learned from FDA Inspections of Foreign API Facilities
Certifying Excipient cGMPs
Certifying Excipient cGMPs
PAT Paves the Way for Continuous Manufacturing
PAT Paves the Way for Continuous Manufacturing
Regulatory Considerations for Controlled Correspondence Related to Generic Drug Chemistry
Regulatory Considerations for Controlled Correspondence Related to Generic Drug Chemistry
The PharmTech/CPhI Connection
Utilizing Run Rules for Effective Monitoring in Manufacturing
Utilizing Run Rules for Effective Monitoring in Manufacturing
Pharmaceutical Technology, September 2015 APIs, Excipients, and Manufacturing Supplement (PDF)
Cleaning of Dedicated Equipment: Why Validation is Needed
Cleaning of Dedicated Equipment: Why Validation is Needed
Excipient Selection for Protein Stabilization
Excipient Selection for Protein Stabilization
Import Testing of Pharmaceutical Products Has Limited Safety Benefits and Can Add Risk to Patients
Import Testing of Pharmaceutical Products Has Limited Safety Benefits and Can Add Risk to Patients
Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Gerresheimer and Bormioli Pharma to Showcase Containment Solutions at Pharmapack

Susan Haigney
January 20th 2025
Article

The two companies will be exhibiting together after Gerresheimer’s December 2024 acquisition of Bormioli.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Almac Sciences Invests £500K in Spectroscopy Lab Instrumentation

Patrick Lavery
January 16th 2025
Article

This investment is additional to and separate from £11 million that was announced in the fall of 2024 for creating new jobs and expanding Almac’s global analytical services capabilities.

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Patrick Lavery
October 30th 2024
Podcast

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Lyndra, Thermo Fisher to Partner on R&D for Long-Acting Oral Therapies

Patrick Lavery
January 15th 2025
Article

The collaboration will leverage Thermo Fisher’s Accelerator Drug Development stable of solutions, which was launched in the fall of 2024.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

Feliza Mirasol
January 15th 2025
Article

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.